Fewer than 1% of patients with renal cell carcinoma are reported to ex
perience spontaneous regression of metastatic lesions after nephrectom
y. We report on 4 of 91 patients (4.4%) with metastatic renal cell car
cinoma who had spontaneous regression of all metastatic lesions after
cytoreductive nephrectomy. These patients were carefully selected befo
re surgery for the ability to receive high dose interleukin-2. One pat
ient had recurrence at 2 months, 1 had recurrence at 11 months, and 2
had no evidence of disease at 3 and 4.5 years.